U.S. Markets open in 1 hr 48 mins

Enzon Pharmaceuticals, Inc. (ENZN)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.24+0.01 (+2.56%)
At close: 3:57PM EDT
People also watch
QLTIALKSPDLIMYGNARQL
Interactive chart
Previous Close0.23
Open0.00
Bid0.38 x 3000
Ask1.41 x 200
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume85,644
Market Cap10.61M
Beta0.76
PE Ratio (TTM)-4.80
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2015-12-30
1y Target EstN/A
Trade prices are not sourced from all markets
  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017
    Capital Cube12 days ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc., Gilead Sciences, ... Read more (Read more...)

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
    Capital Cube2 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc. and Gilead ... Read more (Read more...)

  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
    GuruFocus.com6 months ago

    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    Activist investor continues his interest in penny stock